查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132427

表觀遺傳學市場規模、佔有率和趨勢分析報告：按產品、技術、應用、最終用途、地區和細分市場預測（2026-2033 年）

Epigenetics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

表觀遺傳市場概述

全球表觀遺傳學市場預計到 2025 年將達到 191 億美元，從 2026 年的 219 億美元成長到 2033 年的 632 億美元，2026 年至 2033 年的複合年成長率為 16.4%。

到 2025 年，北美將佔據全球市場最大佔有率，達到 38.7%。這一成長歸功於表觀遺傳學在理解 DNA定序之外的基因調控、支持疾病研究和推進個人化醫療方面發揮的關鍵作用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數與趨勢

  • 市場譜系展望
  • 市場動態
  • 案例研究見解
  • 產業分析工具

第4章：依產品進行業務分析

  • 表觀遺傳市場產品波動分析
  • 表觀遺傳學市場：產品規模與趨勢分析（2021-2033年）
  • 試劑
  • 成套工具
  • 裝置
  • 酵素
  • 服務

第5章：依技術進行業務分析

  • 表觀遺傳市場技術波動分析
  • 表觀遺傳學市場：按技術分類的規模和趨勢分析（2021-2033年）
  • DNA甲基化
  • 組蛋白甲基化
  • 組蛋白乙醯化
  • 大型非編碼RNA
  • 微型RNA修飾
  • 染色質結構

第6章 應用業務分析

  • 按應用分類的表觀遺傳學市場波動分析
  • 表觀遺傳學市場：基於應用的市場規模和趨勢分析（2021-2033年）
  • 腫瘤學
  • 非腫瘤區域

第7章 依最終用途進行業務分析

  • 按最終用途分類的表觀遺傳市場波動分析
  • 表觀遺傳學市場：按最終用途分類的規模和趨勢分析（2021-2033年）
  • 學術研究
  • 臨床研究
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他用戶

第8章：區域商業分析

  • 表觀遺傳學市場佔有率：按地區分類，2025 年和 2033 年
  • 北美洲
    • 2021-2033年北美表觀遺傳學市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲表觀遺傳學市場，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區表觀遺傳學市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲表觀遺傳學市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲表觀遺傳學市場
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場定位/佔有率分析，2025年
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Danaher Corporation（Abcam）
    • Promega Corporation
    • New England Biolabs
    • QIAGEN
    • Merck KGaA（MilliporeSigma）
    • Active Motif
    • EpiCypher
    • Element Biosciences
Product Code: 978-1-68038-583-0

Epigenetics Market Summary

The global epigenetics market size was valued at USD 19.1 billion in 2025 and is projected to grow from USD 21.9 billion in 2026 to USD 63.2 billion by 2033, at a CAGR of 16.4% from 2026 to 2033. North America held the largest share of 38.7% of the global market in 2025. This growth can be attributed to the pivotal role of epigenetics in understanding gene regulation beyond DNA sequencing, aiding disease research, and advancing personalized medicine.

Global Epigenetics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global epigenetics market report on the basis of product, technology, application, end use, and region:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Reagents
  • Kits
    • ChIP sequencing kit
    • Whole Genomic Amplification kit
    • Bisulfite Conversion kit
    • RNA sequencing kit
    • Others
  • Instruments
  • Enzymes
  • Services
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large non - coding RNA
  • MicroRNA modification
  • Chromatin structures
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oncology
    • Solid tumors
    • Liquid tumors
  • Non - oncology
    • Inflammatory diseases
    • Metabolic diseases
    • Infectious diseases
    • Cardiovascular diseases
    • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information Analysis
  • 1.4. Market Formulation & Data Visualization
  • 1.5. Data Validation & Publishing
  • 1.6. Research Assumptions
  • 1.7. Information Procurement
    • 1.7.1. Primary Research
  • 1.8. Information or Data Analysis
  • 1.9. Market Formulation & Validation
  • 1.10. Market Model
  • 1.11. Global Market: CAGR Calculation
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Rising Investment in Precision Medicine
      • 3.2.1.3. Expansion of Epigenetics-Based Drug Discovery
      • 3.2.1.4. Technological Advancements in Sequencing and Multi-Omics
      • 3.2.1.5. Increasing Research Funding and Government Support
      • 3.2.1.6. Rising Biopharmaceutical R&D Expenditure
      • 3.2.1.7. Expansion of Liquid Biopsy and Non-Invasive Diagnostics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of standardization in epigenetics-based diagnostics
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Case Study Insights
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Epigenetics Market Product Movement Analysis
  • 4.3. Epigenetics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
  • 4.4. Reagents
    • 4.4.1. Reagents Market, 2021 - 2033 (USD Billion)
  • 4.5. Kits
    • 4.5.1. Kits Market, 2021 - 2033 (USD Billion)
    • 4.5.2. ChIP sequencing kit
      • 4.5.2.1. ChIP sequencing kit Market, 2021 - 2033 (USD Billion)
    • 4.5.3. Whole Genomic Amplification kit
      • 4.5.3.1. Whole Genomic Amplification kit Market, 2021 - 2033 (USD Billion)
    • 4.5.4. Bisulfite Conversion kit
      • 4.5.4.1. Bisulfite Conversion kit Market, 2021 - 2033 (USD Billion)
    • 4.5.5. RNA sequencing kit
      • 4.5.5.1. RNA sequencing kit Market, 2021 - 2033 (USD Billion)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2021 - 2033 (USD Billion)
  • 4.6. Instruments
    • 4.6.1. Instruments Market, 2021 - 2033 (USD Billion)
  • 4.7. Enzymes
    • 4.7.1. Enzymes Market, 2021 - 2033 (USD Billion)
  • 4.8. Services
    • 4.8.1. Services Market, 2021 - 2033 (USD Billion)

Chapter 5. Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Epigenetics Market Technology Movement Analysis
  • 5.3. Epigenetics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Billion)
  • 5.4. DNA Methylation
    • 5.4.1. DNA Methylation Market, 2021 - 2033 (USD Billion)
  • 5.5. Histone Methylation
    • 5.5.1. Histone Methylation Market, 2021 - 2033 (USD Billion)
  • 5.6. Histone Acetylation
    • 5.6.1. Histone Acetylation Market, 2021 - 2033 (USD Billion)
  • 5.7. Large non - coding RNA
    • 5.7.1. Large non - coding RNA Market, 2021 - 2033 (USD Billion)
  • 5.8. MicroRNA modification
    • 5.8.1. MicroRNA modification Market, 2021 - 2033 (USD Billion)
  • 5.9. Chromatin structures
    • 5.9.1. Chromatin structures Market, 2021 - 2033 (USD Billion)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Epigenetics Market Application Movement Analysis
  • 6.3. Epigenetics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Billion)
  • 6.4. Oncology
    • 6.4.1. Oncology Market, 2021 - 2033 (USD Billion)
    • 6.4.2. Solid tumors
      • 6.4.2.1. Solid tumors Market, 2021 - 2033 (USD Billion)
    • 6.4.3. Liquid tumors
      • 6.4.3.1. Liquid tumors Market, 2021 - 2033 (USD Billion)
  • 6.5. Non - oncology
    • 6.5.1. Non - oncology Market, 2021 - 2033 (USD Billion)
    • 6.5.2. Inflammatory diseases
      • 6.5.2.1. Inflammatory diseases Market, 2021 - 2033 (USD Billion)
    • 6.5.3. Metabolic diseases
      • 6.5.3.1. Metabolic diseases Market, 2021 - 2033 (USD Billion)
    • 6.5.4. Infectious diseases
      • 6.5.4.1. Infectious diseases Market, 2021 - 2033 (USD Billion)
    • 6.5.5. Cardiovascular diseases
      • 6.5.5.1. Cardiovascular diseases Market, 2021 - 2033 (USD Billion)
    • 6.5.6. Others
      • 6.5.6.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Epigenetics Market End Use Movement Analysis
  • 7.3. Epigenetics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
  • 7.4. Academic Research
    • 7.4.1. Academic Research Market, 2021 - 2033 (USD Billion)
  • 7.5. Clinical Research
    • 7.5.1. Clinical Research Market, 2021 - 2033 (USD Billion)
  • 7.6. Hospitals & Clinics
    • 7.6.1. Hospitals & Clinics Market, 2021 - 2033 (USD Billion)
  • 7.7. Pharmaceutical & Biotechnology Companies
    • 7.7.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Billion)
  • 7.8. Other Users
    • 7.8.1. Other Users Market, 2021 - 2033 (USD Billion)

Chapter 8. Regional Business Analysis

  • 8.1. Epigenetics Market Share by Region, 2025 & 2033
  • 8.2. North America
    • 8.2.1. North America Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. U.S. Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Canada Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Mexico Epigenetics Market, 2021 - 2033 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. UK Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Germany Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. France Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Italy Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Spain Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Denmark Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Sweden Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Norway Epigenetics Market, 2021 - 2033 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Japan Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. China Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. India Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Australia Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Thailand Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. South Korea Epigenetics Market, 2021 - 2033 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Brazil Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Argentina Epigenetics Market, 2021 - 2033 (USD Billion)
  • 8.6. MEA
    • 8.6.1. MEA Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. South Africa Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Saudi Arabia Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. UAE Epigenetics Market, 2021 - 2033 (USD Billion)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Kuwait Epigenetics Market, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position/Share Analysis, 2025
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Illumina, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Danaher Corporation (Abcam)
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Promega Corporation
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. New England Biolabs
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. QIAGEN
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA (MilliporeSigma)
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Active Motif
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. EpiCypher
      • 9.4.9.1. Overview
      • 9.4.9.2. Product Benchmarking
      • 9.4.9.3. Financial Performance
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Element Biosciences
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global epigenetics market, by region, 2021 - 2033 (USD Billion)
  • Table 3 Global epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 4 Global epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 5 Global epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 6 Global epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 7 North America epigenetics market, by country, 2021 - 2033 (USD Billion)
  • Table 8 North America epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 9 North America epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 10 North America epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 11 North America epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 12 U.S. epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 13 U.S. epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 14 U.S. epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 15 U.S. epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 16 Canada epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 17 Canada epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 18 Canada epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 19 Canada epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 20 Mexico epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 21 Mexico epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 22 Mexico epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 23 Mexico epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 24 Europe epigenetics market, by country, 2021 - 2033 (USD Billion)
  • Table 25 Europe epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 26 Europe epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 27 Europe epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 28 Europe epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 29 Germany epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 30 Germany epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 31 Germany epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 32 Germany epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 33 UK epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 34 UK epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 35 UK epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 36 UK epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 37 France epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 38 France epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 39 France epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 40 France epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 41 Italy epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 42 Italy epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 43 Italy epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 44 Italy epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 45 Spain epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 46 Spain epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 47 Spain epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 48 Spain epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 49 Denmark epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 50 Denmark epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 51 Denmark epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 52 Denmark epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 53 Sweden epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 54 Sweden epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 55 Sweden epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 56 Sweden epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 57 Norway epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 58 Norway epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 59 Norway epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 60 Norway epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 61 Asia Pacific epigenetics market, by country, 2021 - 2033 (USD Billion)
  • Table 62 Asia Pacific epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 63 Asia Pacific epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 64 Asia Pacific epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 65 Asia Pacific epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 66 China epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 67 China epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 68 China epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 69 China epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 70 Japan epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 71 Japan epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 72 Japan epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 73 Japan epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 74 India epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 75 India epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 76 India epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 77 India epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 78 South Korea epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 79 South Korea epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 80 South Korea epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 81 South Korea epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 82 Australia epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 83 Australia epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 84 Australia epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 85 Australia epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 86 Thailand epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 87 Thailand epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 88 Thailand epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 89 Thailand epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 90 Latin America epigenetics market, by country, 2021 - 2033 (USD Billion)
  • Table 91 Latin America epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 92 Latin America epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 93 Latin America epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 94 Latin America epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 95 Brazil epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 96 Brazil epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 97 Brazil epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 98 Brazil epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 99 Argentina epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 100 Argentina epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 101 Argentina epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 102 Argentina epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 103 MEA epigenetics market, by country, 2021 - 2033 (USD Billion)
  • Table 104 MEA epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 105 MEA epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 106 MEA epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 107 MEA epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 108 South Africa epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 109 South Africa epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 110 South Africa epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 111 South Africa epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 112 Saudi Arabia epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 113 Saudi Arabia epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 114 Saudi Arabia epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 115 Saudi Arabia epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 116 UAE epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 117 UAE epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 118 UAE epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 119 UAE epigenetics market, by end use, 2021 - 2033 (USD Billion)
  • Table 120 Kuwait epigenetics market, by product, 2021 - 2033 (USD Billion)
  • Table 121 Kuwait epigenetics market, by technology, 2021 - 2033 (USD Billion)
  • Table 122 Kuwait epigenetics market, by application, 2021 - 2033 (USD Billion)
  • Table 123 Kuwait epigenetics market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Epigenetics market: Market outlook
  • Fig. 5 Epigenetics market: Segment outlook
  • Fig. 6 Epigenetics market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Epigenetics market driver impact
  • Fig. 9 Epigenetics market restraint impact
  • Fig. 10 Epigenetics market: Product outlook and key takeaways
  • Fig. 11 Epigenetics market: Product movement analysis
  • Fig. 12 Reagents market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 13 Kits market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 14 ChIP sequencing kit market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 15 Whole genomic amplification kit market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 16 Bisulfite conversion kit market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 17 RNA sequencing kit market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 18 Others market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 19 Instruments market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 20 Enzymes market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 21 Services market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 22 Epigenetics market: Technology outlook and key takeaways
  • Fig. 23 Epigenetics market: Technology movement analysis
  • Fig. 24 DNA methylation market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 25 Histone methylation market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 26 Histone acetylation market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 27 Large non -coding RNA market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 28 MicroRNA modification market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 29 Chromatin structures market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 30 Epigenetics market: Application outlook and key takeaways
  • Fig. 31 Epigenetics market: Application movement analysis
  • Fig. 32 Oncology market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Solid tumors market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 Liquid tumors market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 35 Non - oncology market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 36 Inflammatory diseases market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 37 Metabolic diseases market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 38 Infectious diseases market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 39 Cardiovascular diseases market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 40 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 41 Epigenetics market: End Use outlook and key takeaways
  • Fig. 42 Epigenetics market: End Use movement analysis
  • Fig. 43 Academic research market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 Clinical research market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 45 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Billion)
  • Fig. 47 Other users market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 48 Global epigenetics market: Regional outlook and key takeaways
  • Fig. 49 Global epigenetics market: Regional movement analysis
  • Fig. 50 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 52 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 57 France market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 61 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 63 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 China market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 65 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 66 India market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 67 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 68 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 71 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 72 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 74 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 76 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)